The Tim Ferriss Show

#875: The Random Show — Tim and Kevin Talk Retreats, Mortality, AI Predictions, Supplements, Rock Climbing at (Almost) 50, and Not Waiting for “Someday”

3005 snips
Jul 16, 2026
Two friends trade stories over tequila about Zen retreats, five days of silence, and confronting mortality. They talk learning rock climbing near 50, finger-strength training, and long-term fitness hacks. Conversation ranges from supplements and sleep apnea tips to AI predictions, using AI for personal retrospectives, and tools for productivity and audio gear.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Single Lisergic Dose Showed 12 Week Anxiety Benefits

  • A single dose of MM-120 (lisergic compound similar to LSD) produced dose-dependent reduction in generalized anxiety disorder up to 12 weeks in a randomized trial, with 100 micrograms appearing minimally effective.
  • Tim connects this to broader interest in psychedelics for neuropsychiatric use but flags ethical questions for vulnerable populations.
INSIGHT

Psychedelics Sometimes Trigger Transient Lucidity In Dementia

  • Case reports show high-dose psilocybin or LSD can transiently increase verbal fluidity and lucidity in some dementia patients, echoing phenomena like terminal lucidity.
  • These are anecdotal and ethically fraught, but they suggest psychoactive interventions may momentarily restore communication.
ADVICE

Use LLMs To Rapidly Spot Medication And Supplement Risks

  • Use LLMs to cross-check medication, supplement interactions, and acute symptom explanations to avoid dangerous combinations quickly. Tim Ferriss recommends fact-checking across models to reduce hallucinations.
  • Treat AI as a rapid research co-pilot for triage, not a final clinical authority.
Get the Snipd Podcast app to discover more snips from this episode
Get the app